Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Automated Compounding Devices Market’s Growth Trajectory From 2025 To 2034?

The market size of automated compounding devices has seen robust growth over the past few years. The market, which was valued at $2.36 billion in 2024, is projected to reach $2.51 billion in 2025, representing a compound annual growth rate (CAGR) of 6.6%. The significant growth during this historic period is linked to a surge in chronic diseases, an older population, development in the healthcare infrastructure, new governance norms, and a rising number of medication errors.

The market for automated compounding devices is projected to experience robust expansion in the upcoming years, reaching a value of $3.3 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. Factors contributing to the growth during the forecast period include escalating cancer rates, worldwide healthcare development, heightened attention on patient safety, regulatory backing, and an escalating emphasis on sustainability. Key trends forecasted for this period are telemedicine, remote healthcare, progress in artificial intelligence, the digital transformation of healthcare, and real-time monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Automated Compounding Devices Market?

The growth of the automated compounding devices market is expected to be propelled by the rising count of personalized medicines. Personalized medicine is a healthcare approach that adjusts medical decisions, procedures, interventions, and treatments according to the unique specifics of each patient. This surge in personalized medicines can be attributed to improved genetics knowledge, specific patient data, and regulatory backing. Automated compounding devices (ACDs) are vital in personalized medicine as they facilitate the meticulous and exact preparation of custom drug compounds that are adjusted to meet individual patient requirements. These devices mechanize the task of mixing multiple pharmaceutical components in precise ratios, which is crucial for generating customized treatment plans. For example, the Personalized Medicine Coalition, a non-profit organization based in the USA, stated in February 2024 that the FDA granted approval for 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from six in 2022. Hence, the rising prevalence of personalized medicines is fueling the expansion of the automated compounding devices market.

Which Primary Segments of the Automated Compounding Devices Market Are Driving Growth and Industry Transformations?

The automated compounding devicesmarket covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software

2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems

3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems

4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)

2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Automated Compounding Devices Market?# Market?

North America was the largest region in the automated compounding devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Automated Compounding Devices Market?

Key players in the automated compounding device market are making strides to minimize medication errors and boost patient safety by utilizing advanced technologies such as robotic compounding technology. This strategy aims to deepen customer trust, align with regulatory standards, and secure a leading edge in the competition. Robotic compounding technology automates the methodical production and blending of drug compounds through high-tech robotic systems, magnifying precision, productivity, and safety in drug preparation. For example, Omnicell Inc., a healthcare technology firm in the US, introduced the IVX Station, an innovative automated compounding device, in March 2022. This cutting-edge solution is designed to extend the reach of IV robotic technology in the wider market, improving patient safety, precision, cost-effectiveness, supply chain operations, and regulatory adherence. The IVX Station has three times the speed of existing IV robotic systems, features a fail-safe design to limit downtime and retains a compact size suitable for pharmacy tasks.

View the full report here:

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

What Parameters Are Used to Define the Automated Compounding Devices Market?

Automated compounding devices refer to specialized equipment designed to automate the preparation of medications, including intravenous (IV) solutions, in healthcare settings. These devices ensure precise and efficient compounding, enhancing patient safety and reducing the risk of human error in medication preparation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model